Biosynthesis and incorporation into protein of norleucine by Escherichia coli.
The methionine analog norleucine was produced during the synthesis of bovine somatotropin by Escherichia coli strain W3110G containing the recombinant plasmid pBGH1. Norleucine was generated by the leucine biosynthetic pathway from pyruvate or alpha-ketobutyrate in place of alpha-ketoisovalerate as the initial substrate. The intracellular level of norleucine was high enough to permit the analog to compete successfully with methionine for incorporation into protein. Two ways were found to prevent either the formation of norleucine or its incorporation into protein. The endogenous synthesis of norleucine was eliminated by deleting the leucine operon. The addition of sufficient methionine or 2-hydroxy-4-methylthiobutanoic acid, a precursor of methionine, to the culture medium prevented any norleucine from being incorporated into protein.
Bogosian
G
G
Animal Sciences Division, Monsanto Corp., Chesterfield, Missouri 63198.
Violand
B N
BN
Dorward-King
E J
EJ
Workman
W E
WE
Jung
P E
PE
Kane
J F
JF
D000596:Amino Acids / Q000032:analysis; D000614:Aminocaproates / Q000096:biosynthesis*; D000818:Animals; D002417:Cattle; D002851:Chromatography, High Pressure Liquid; D004926:Escherichia coli / Q000235:genetics* / Q000254:growth & development; D005285:Fermentation; D005838:Genotype; D013006:Growth Hormone / Q000096:biosynthesis*; D009646:Norleucine / Q000096:biosynthesis* / Q000378:metabolism; D010957:Plasmids; D011994:Recombinant Proteins / Q000096:biosynthesis*; D014161:Transduction, Genetic
D000596:Amino Acids; D000614:Aminocaproates; D011994:Recombinant Proteins; D009646:Norleucine; D013006:Growth Hormone